International Consolidated Airlines Group (IAG), GB00B128C026

IAG Cargo Constant Climate from International Consolidated Airlines Group - tailored air freight for temperature-sensitive goods

Published on 07/04/2026 at 18:33 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

IAG Cargo Constant Climate moves temperature-sensitive medicines and perishables in controlled conditions across IAG’s global network. Anyone holding International Consolidated Airlines Group stock (LSE: IAG, ISIN GB00B128C026) should know this product.

International Consolidated Airlines Group (IAG), GB00B128C026, Illustration mit AI erstellt.
International Consolidated Airlines Group (IAG), GB00B128C026, Illustration mit AI erstellt.

By Nora Whitfield, ad hoc news B2B & Pro Desk. Reviewed July 04, 2026, 4:33 PM ET. Details in the imprint.

IAG Cargo Constant Climate is easiest to understand if you picture a pallet of insulin rolling off a cool truck into a dimly lit warehouse and straight into a chilled airside container, vapor curling in the night air as ground staff rush to close the doors.

What Constant Climate actually does

Constant Climate is IAG Cargo’s specialized cold-chain air freight solution designed for temperature-sensitive pharmaceuticals and high-value life science products. It offers active and passive temperature-controlled options, including refrigerated containers and dedicated cool rooms at key hubs, plus 24/7 monitoring for selected lanes.

Through British Airways, Iberia and other IAG airlines, the service connects major pharma production centers in Europe and North America with markets in Latin America, Asia and Africa. Unlike standard air freight, Constant Climate is built around maintaining tight temperature ranges, often between 2°C and 8°C or 15°C and 25°C, from tender to delivery.

How the service is structured for shippers

IAG Cargo sells Constant Climate as a premium product on top of its general cargo rates, with price tiers depending on container type, lane complexity, and value-added services such as real-time tracking, tarmac transfers, or dry ice handling. For a US-based biotech exporter, that can mean a predictable surcharge in exchange for tighter risk control on every shipment.

To book, freight forwarders or pharma shippers work through IAG Cargo’s specialized pharma desk, which builds routings around certified stations and compatible aircraft types. Sales managers talk about “lanes” rather than flights, because the product is defined by certified corridors where all handling steps meet Good Distribution Practice (GDP) or comparable standards.

Dig deeper

Constant Climate and IAG Cargo’s pharma strategy

More background on how IAG Cargo positions its cold-chain business inside International Consolidated Airlines Group and why institutional investors watch premium cargo closely.

US relevance and network reach

For US-based investors and shippers, the key hook is that Constant Climate rides on IAG’s transatlantic passenger fleet. Widebody aircraft from British Airways and Iberia connect hubs like London Heathrow and Madrid with major US gateways such as New York, Chicago, Miami and Los Angeles, turning belly space into a high-yield cargo channel.

A US pharma exporter moving clinical trial material from Boston to a site in SĂŁo Paulo might see Constant Climate used on the connecting leg through Heathrow or Madrid. The product effectively monetizes existing aircraft holds by layering specialized handling on top of scheduled flights that would operate anyway.

Operational backbone and people behind it

The operation depends on a web of certified cargo terminals, handling partners and trained staff. IAG Cargo highlights its Constant Climate Centers at London Heathrow and Madrid, where dedicated pharma zones feature temperature-controlled storage, build-up areas and monitoring systems.

People like Camilo Garcia Cervera, a long-time air cargo executive associated with IAG Cargo’s growth in pharma and premium products in past years, helped shape this product category by pushing for more consistent global standards and more transparent communication with big pharma accounts. The commercial conversations often go far beyond simple weight-and-rate quotes.

Risk management for temperature excursions

From a shipper’s perspective, one of the main reasons to pay for Constant Climate is risk mitigation. Temperature excursions can render entire lots of medicine unusable. That risk carries both direct cost and reputational exposure, especially with regulators and hospitals.

Constant Climate contracts typically include documented handling procedures, options for data loggers, and in some cases contractual remedies for proven deviations. The exact terms are negotiated with forwarders and pharma companies, but the value proposition revolves around reducing the probability and impact of those excursions along complex multi-leg routings.

Regulatory backdrop and certification pressure

Pharmaceutical logistics is heavily regulated, and regulators increasingly expect documented cold-chain compliance. For IAG Cargo, Constant Climate is a way to align with Good Distribution Practice guidelines and to appeal to shippers who undergo their own regular audits by authorities and quality teams.

To win and retain tenders with major pharma manufacturers, carriers like IAG must show station-level audits, training records, and incident statistics. Constant Climate is structured to make that documentation easier to present, while also giving the sales team a clearly defined product they can price and promote.

Competitive landscape in pharma air freight

IAG Cargo is not alone in chasing pharma business. Large peers such as Lufthansa Cargo, Air France-KLM Martinair Cargo and Emirates SkyCargo operate their own branded cold-chain products. Competition shows up in specialized features, network coverage, and the reliability track records that shippers share informally.

For investors, the strategic point is that pharma cargo is among the more resilient demand segments. It can help smooth revenue volatility when general cargo rates soften. Constant Climate positions IAG to participate in that segment instead of leaving it to rivals and integrators.

Digital tools and tracking expectations

On the digital side, Constant Climate is gradually pulling in more real-time data. While many shippers still rely on attached data loggers, IAG Cargo has been adding options for lane-based temperature monitoring, digital status updates and exception alerts, often in cooperation with container leasing partners and tracking technology firms.

In practice, a logistics manager may sit in a fluorescent-lit office, watching a dashboard that flags if a pallet sits too long on the tarmac in Madrid or gets delayed in customs. That kind of visibility has become a standard expectation for high-value pharma shipments, not a nice-to-have extra.

Practical constraints and capacity limits

Constant Climate is constrained by available space in temperature-controlled containers, cool rooms and aircraft holds. During peak seasons such as vaccine campaigns or flu season, shippers can find space tight on the corridors they need most.

IAG Cargo has to juggle those premium bookings against other high-yield cargo like express e-commerce or electronics. Yield management teams constantly decide which mix of freight optimizes revenue while honoring service commitments, and Constant Climate bookings usually sit near the top of that priority list.

What this means for IAG’s broader business

For International Consolidated Airlines Group, cargo is just one part of the story next to passenger revenue and maintenance services. Within cargo, Constant Climate is a relatively small but higher-yield slice that fits the group’s focus on using its hubs to move value-dense goods efficiently.

That matters for institutional holders of IAG stock (LSE: IAG, ISIN GB00B128C026) because premium cargo offerings like Constant Climate can support margins through the cycle even when passenger yields are under pressure.

Key facts: IAG Cargo Constant Climate

  • Product: IAG Cargo Constant Climate
  • Manufacturer: International Consolidated Airlines Group SA
  • Category: B2B / Pro air freight service
  • Launch: Ongoing product, branded and expanded over the past decade as pharma-focused cold-chain service
  • MSRP / Price: Premium cargo rates based on route, weight and service options
  • Availability: Offered on selected routes across the IAG Cargo network, including transatlantic and Europe-Latin America lanes
  • Target audience: Pharmaceutical manufacturers, biotech firms, clinical trial logistics providers and specialized freight forwarders
  • Standout / USP: Dedicated cold-chain handling over IAG’s long-haul passenger network with temperature-controlled facilities at key hubs

Follow IAG Cargo Constant Climate

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | GB00B128C026 | INTERNATIONAL CONSOLIDATED AIRLINES GROUP (IAG) | boerse | 69690376 | bgmi